Sheffield to market Wockhardt's recombinant insulin in cell culture sector
22 February 2011
Anju Ghangurde
Please Login to read the full article.
22 February 2011
Anju Ghangurde
aghangurde@yahoo.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pfizer in investment phase in India as it moves into diabetes and branded generics
- Wockhardt divests nutrition to Danone but lender issues skid stock
- BMS and Sanofi mentioned in $1bn deal speculation over Biocon's oral insulin
- Lupin licenses NeuClone's cell line as it builds biologics interests
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
